Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Brighter appoints Deputy Managing Director of the company's UAE subsidiary.

Hamza Moftah has been appointed Deputy Managing Director of Brighter’s subsidiary in the United Arab Emirates, established August 2018 in collaboration with Brighter’s partner AFAQ Group. Hamza is an experienced business developer with extensive knowledge of the United Arab Emirates and the broader GCC/MENA region, in particular within the MedTech, Digital Health and Pharmaceutical industries and has previously held senior positions in EY and Cerner. As Deputy Managing Director, Hamza Moftah is the primary point of contact for Brighter's local partnerships and operations. He also plays a

Greater Than enters partnership with Zurich Insurance and Sixt Ireland

Insurtech company Greater Than enters the Irish market by entering a partnership with Zurich Insurance UK and Sixt Ireland. With a common goal to increase safety and driver influence in the car rental industry, the partners will implement Greater Than’s AI-based, digital risk assessment platform on the entire Sixt car fleet on Ireland - giving more than 3500 vehicles a new, user-based management tool.The partnership makes way for Zurich Insurance and car rental company Sixt on Ireland to integrate a user-based, digital risk assessment and fleet management solution on the entire Irish Sixt

Evolution creates dedicated studio for Ardent Group Live Casino TV show in Belgium

Evolution Gaming, leading provider of Live Casino solutions, has announced that it is powering a Circus.be-branded Live Casino TV show in Belgium for long-standing customer, the Liege-based Ardent Group.Ardent’s Circus TV show airs for three hours every day from midnight to 3:00am local time and is now live. In the live show, a TV presenter moves between Evolution-powered Live Casino tables and a separate sports area of the studio, interacting with game players and sports bettors. A dedicated Live Casino studio has been created for the show by Evolution within an existing third-party

Sivers IMA presents at Redeye Technology Day 2018

On 20th of November, Anders Storm, CEO of Sivers IMA Holding AB (Nasdaq First North: SIVE, the Company) will participate at Redeye Technology Day together with some of the most interesting tech companies in Scandinavia.The event will be held at Haymarket by Scandic, Hötorget 13-15, Stockholm at 08.00-16.00. The presentation will also be broadcasted live and can be followed at: https://www.redeye.se/live/tech-day-2018      The presentations will be posted on redeye.se and on the Company's website in Redeye Universe https://www.redeye.se/company/sivers-ima For more information,

Alfa Laval wins SEK 175 million offshore orders

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won two orders to supply Framo pumping systems to oil platforms in the North Sea. The orders have a combined value of approximately SEK 175 million. They are booked in the Pumping Systems unit of the Marine Division, with deliveries scheduled for 2019.The orders comprise offshore pumping systems for firewater and for injection of sea water into the production wells in order to optimize the extraction of oil. “I am pleased to announce these large orders for our Framo pumping systems. Framo

Heading towards zero emission airports – Lapland Airports in Finland switch to Neste MY Renewable Diesel

Neste Corporation Press Release 13 November 2018 at 9.30 am. (EET) The Finnish airport operator Finavia has decided to adopt  Neste MY Renewable Diesel ™ in its vehicles at Rovaniemi, Kuusamo, Ivalo and Kittilä airports. Neste MY Renewable Diesel is produced from waste and residues. The switch to renewable fuel is part of Finavia’s goal to make its airports carbon dioxide neutral by 2020. “Helsinki Airport is already carbon dioxide neutral. Next we will aim to achieve the same in our airports in Lapland.

Done with hotels?

Traditional hotels serve their purpose but if you’re looking for comfort and home-like living combined with the benefits of a hotel – serviced apartments are the way to go.Serviced apartments are a rapidly growing trend in the travel industry. Travellers that have previously been confined to a small hotel room have now recognised the advantages of serviced apartments: more space, convenience and privacy at a lower cost. The Finnish company Forenom is on the forefront of this trend, offering home-like accommodation all around the Nordics.  “Nowadays, many people want to live like a

Coloreel wins the largest innovation award in Sweden

This year’s winner of the prestigious Innovation award, the SKAPA prize is Joakim Staberg and his Coloreel who has developed a unique machine for digital thread coloring that will revolutionize the textile industry. This places Coloreel as one of the most innovative companies in the world since Sweden is ranked as the 2nd most innovative country in the world according to 2018 Bloomberg Innovation Index. Joakim Staberg received this year’s award of 500 000 SEK from the Foundation

AstraZeneca to divest US Synagis rights to Sobi

This announcement contains inside information 13 November 2018 07:00 GMT AstraZeneca to divest US Synagis rights to Sobi Transaction grants Sobi the right to participate in US profits and losses for MEDI8897 Upfront consideration of $1.5bn plus further contingent payments AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV) to Swedish Orphan Biovitrum AB (publ) (Sobi). Sobi will commercialise Synagis in the US and around 130 AstraZeneca

BioArctic to present at Jefferies 2018 London Healthcare Conference on November 15

Stockholm, Sweden, November 13, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will present at Jefferies 2018 London Healthcare Conference on November 15, at 4.40 p.m. local time (GMT). BioArctic is a research-based biopharmaceutical company focusing on disease modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. The company also develops a treatment for complete spinal cord injury. The company focuses on new types of treatments in areas with high unmet medical needs. BioArctic was founded in 2003 based on

First distribution channels announced for Heroes & Superstars

Nitro Games announced the first distribution channels for the upcoming reality show Heroes & Superstars The first distribution channels announced are: ·  Huawei Video service ·  Twitch ·  Viafree & Viaplay ·  Sport1 ·  Youtube Heroes & Superstars is a new challenging reality competition show where nine gaming superstars and three extreme sport stars will battle out in Heroes of Warland against each other. The premiere of Heroes & Superstars will sync with the launch of Heroes of Warland and premiere in 2018. Heroes & Superstars is produced by Gamingzone

Interim report January - September 2018

Third quarter 2018 · Revenues amounted to SEK 225.0 (180.7) million, an increase by 25 % compared to the same period last year. · Operating profit amounted to SEK 68.3 (52.9) million, an increase by 29 %. · Profit before tax amounted to SEK 68.3 (52.6) million, and profit after tax amounted to SEK 52.9 (40.6) million. · Cash flow from operating activities amounted to SEK 97.4 (70.3) million, and cash flow from investing activities amounted to SEK -82.4 (-79.2) million. · By the end of the period cash and short-term placements amounted to SEK 344.1 (244.3) million. ·

Swedish real estate companies give Swedbank top ranking in annual customer satisfaction survey

Swedbank has once again been ranked #1 in Prospera’s annual customer satisfaction survey, Corporate Banking 2018 Real Estate Sweden. This is the second year in a row that Swedbank has achieved a first-place ranking.Kantar Sifo Prospera’s annual client- and market survey shows that Swedbank is once again in first place, with a top ranking in half of the categories in the survey. Real estate clients assessed Swedbank and other banks on criteria such as personal contacts; service-mindedness, coordination of offering; specialist competence; strategic advice; customised solutions and active

REVISED STRATEGY TO GENERATE NEW BUSINESS

INTERIM REPORT FOR THE PERIOD JANUARY TO SEPTEMBER 2018THIRD QUARTER  · Net sales for the remaining operation totaled SEK 16.8 (10.1) million. · The operating profit/loss for the remaining operation totaled SEK -0.4 (-6.5) million. · The profit/loss for the remaining operation totaled SEK -0.7 (-7.5) million. · Earnings per share for the remaining operation totaled SEK 0.00 (-0.02). · Earnings per share for the total operation totaled SEK 0.00 (-0.02). · Cash flow from total operating activities totaled SEK -0.2 (3.9) million. INTERIM PERIOD · Net sales for the

Loomis is awarded SafePoint contract in the US

Loomis AB’s subsidiary in the US is excited to announce it has signed a five-year contract to install and service approximately 1,000 new SafePoint units for a national convenience store chain. The agreement also includes an extension of 250 units, which previously have been installed. The total estimated value of the contract is USD 48 million through 2023. The installation of the units is expected to start in the fourth quarter this year and be completed by early 2020. “This award shows the continued demand for automating cash operations in the US and our SafePoint solution continues

Sobi™ to acquire Synagis® US rights from AstraZeneca - creates a platform for global growth

Sobi™ to acquire Synagis® US rights from AstraZeneca - creates a platform for global growth Swedish Orphan Biovitrum AB (publ)  (Sobi™) (STO:SOBI) has entered into agreements to acquire the perpetual rights to Synagis® (palivizumab) in the US from AstraZeneca and to participate in 50 per cent of the future earnings of the candidate drug MEDI8897 in the US. The total upfront consideration corresponds to USD 1,500 M (SEK 13.6 B[1] 

Interim report

January 1 – September 30, 2018The third quarter in figures · Net sales amounted to TSEK 1,359 (1,172). · The loss after tax including an extraordinary one-time charge amounted to TSEK 12,754 (8,810). · The loss per share amounted to SEK 0.77 (1.06). · The cash flow from current operations was negative in the amount of TSEK 7,692 (9,796). · The gross margin was 52.6% (56.8%). · Electrode sales in volume decreased by 10% and reached 3,088 (3,440) units. Repeat sales of electrodes decreased by 19% partly affected by timing of purchases and partly by customers having a “wait

Basware Scores Highest for Ease of Deployment

Magic Quadrant for Procure-to-Pay Suites Demonstrates Global SuitabilityESPOO, Finland – November 12, 2018 – Basware (Nasdaq: BAS1V), the global leader in networked source-to-pay solutions, e-invoicing and innovative financing services, was recognized as a leader in the 2018 Gartner Magic Quadrant for Procure-to-Pay Suites for the third consecutive time. Basware was named to the leadership quadrant because of its strong market understanding, vertical industry strategy, product offering and customer experience. “Basware provides the adaptability companies in the global marketplace require,

Componenta Corporation Business Review January-September 2018

'Componenta Corporation Stock Exchange Release on 13 November 2018 at 8:00 Adjusted operating result increased from last year for continued operations. The information presented in this financial statement release relates to the development of continued operations of Componenta Group in January-September 2018 and in the comparison period in 2017, unless otherwise stated. Continued operations in the review period were the foundry operations in Pori and Karkkila, Finland, and the machine shop in Främmestad, Sweden. In alternative performance measures, certain value adjustment items not

Ambea interim report July-September 2018

CEO comment: Like the preceding quarter, the third quarter showed strong profitability and growth. The adjusted EBITA margin improved one percentage point year-on-year, and Ambea continued to deliver positive growth in own management. The acquisition of Aleris’ care operations will broaden our growth platform, and make us the largest care provider in Sweden, Norway and Denmark with a strong pipeline of own management beds. Integration and synergy realization planning is ongoing pending competition authorities approval ahead of closing of the transaction, which is expected in Q1 2019.

Insr Insurance Group third quarter 2018 results: Pricing to beat claims inflation

Oslo,  November 13th, 2018 Insr Insurance Group ASA (OSE:INSR) announces results for the third quarter of 2018. A presentation of the results by the Group’s senior management team will take place today at 08:30 CET - see details below. The premium portfolio growth was strong this quarter, adding substantial wholesale volume both in Norway and Denmark. The 19% annualized growth rate year to date is well ahead of  the medium term target of low double digit growth. The gross combined ratio was 97.7%, driven by improved loss ratio, meaning that the underlying business is profitable

Panoro Energy Announces Third Quarter 2018 Results and Provides Operations and Corporate Updates

Oslo, November 13, 2018 - Panoro Energy (the “Company” or “Panoro” with OSE ticker: “PEN”) today announces the third quarter 2018 financial results and subsequent events: Highlights · Successive transactions in Tunisia and first oil at Dussafu have substantially transformed Panoro · Nine-fold approximate increase in production as compared to Q2 2018 (on a pro-forma basis including company in the process of being acquired) · Material increase in reserves, resources, and exploration potential Dussafu · Phase 1 development completed on time and on budget; first oil

BerGenBio ASA: Results for the Third Quarter 2018

· Phase II data in NSCLC with bemcentinib/KEYTRUDA combination: First stage of trial in previously treated patients reported 40% ORR and ca. 6 months median PFS in AXL positive patients, stage 2 actively enrolling patients · Additional NSCLC data: Bemcentinib/TARCEVA phase II combination trial in first line EGFRm patients reported that median PFS has surpassed that of TARCEVA monotherapy, encouraging efficacy reported in combination trial with docetaxel in later line patients · Pipeline update: IND filed for AXL antibody BGB149Bergen, Norway, 13 November 2018 – BerGenBio ASA (OSE:

There are no items matching the current filter
There are no more items matching the current filter
Back to top